Search results for: Consulting Reports
Filter search results
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…these barriers, which were developed through an expert roundtable project, sponsored by Pfizer, soon to be published as an OHE Consulting Report. Louis Garrison (Professor Emeritus at the CHOICE Institute,…
The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis
30 June 2022
…value of a novel orphan medicine. Related research Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Garau,…
Medical Manpower
7 January 1966
…disease, consulting a random physician, had a better than fifty-fifty chance of benefiting from the encounter’. Medical progress since then, and especially in the last two decades, has been more…
Obstructive Sleep Apnoea: Health Economics Report
1 September 2014
…85% of OSA cases currently are undiagnosed and untreated in the UK. In this report, OHE Consulting calculates the direct savings that could be realised if more cases were treated….
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
…in 2013. In order to do this, OHE Consulting and RAND Europe conducted analyses of four case study projects: 1. Anxiety & Depression Clinical Network: A targeted 5% improvement in…
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…to vary according to indication and – critically – according to value. This OHE Consulting report, funded by AstraZeneca, provides an overview of the key literature that has contributed to…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…are poorly understood, particularly in relation to the new General Data Protection Regulation (GDPR). In this consulting report, sponsored by the European Federation of Pharmaceutical Industries and Associations (EFPIA), we…
Exploring the Financial Sustainability of Gene Therapies
5 January 2021
…Journal of Health Economics, DOI: https://doi.org/10.1007/s10198-018-1007-x Hampson G, Mott D, Shah K, Devlin N., 2018. Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. OHE Consulting Report, London:…